Table 3.
Radiologic criteria – univariate analysis
| Criteria | Rate of having gross residual disease | OR | 95% CI | p | |
|---|---|---|---|---|---|
| Criteria present | Criteria absent | ||||
| Perihepatic lesion | 88/121 (73%) | 145/229 (63%) | 1.54 | 1.5 – 1.6 | <.001 |
| Subcapsular liver lesion | 35/52 (67%) | 198/298 (66%) | 1.04 | 0.6 – 1.8 | .89 |
| Liver intraparenchymal lesion | 8/11 (73%) | 225/339 (66%) | 1.35 | 1.1 – 1.7 | .007 |
| Spleen intraparenchymal lesion | 6/9 (67%) | 227/341 (67%) | 1 | 0.99 – 1.02 | .58 |
| Lesion in splenic hilum/ligaments | 56/70 (80%) | 177/280 (63%) | 2.33 | 2.1 – 2.6 | <.001 |
| Lesser sac lesion >1 cm | 31/35 (89%) | 202/315 (64%) | 4.34 | 3.3 – 5.7 | <.001 |
| Gastrohepatic ligament/Porta hepatis lesion | 71/88 (81%) | 162/262 (62%) | 2.58 | 2 – 3.3 | <.001 |
| Gallbladder fossa/Liver intersegmental fissure lesion | 69/85 (81%) | 164/265 (62%) | 2.66 | 1.9 – 3.7 | <.001 |
| Omental lesion | 142/220 (65%) | 91/130 (70%) | 0.78 | 0.5 – 1.3 | .33 |
| Root of the superior mesenteric artery lesion | 12/13 (92%) | 221/337 (66%) | 6.3 | 5.1 – 7.8 | <.001 |
| Small bowel mesentery lesion | 49/67 (73%) | 184/283 (65%) | 1.46 | 1.3 – 1.7 | <.001 |
| Retroperitoneal lymph nodes above the renal hilum (including supradiaphragmatic) | 71/94 (76%) | 162/256 (63%) | 1.79 | 1.7 – 1.9 | <.001 |
| Pulmonary metastasis (lung bases) | 9/13 (69%) | 224/337 (66%) | 1.14 | 0.98 – 1.3 | .08 |
| Pleural metastasis (lung bases) | 9/17 (53%) | 224/333 (67%) | 0.55 | 0.3 – 0.9 | .02 |
| Tumor invading anterior abdominal wall | 12/16 (75%) | 221/334 (66%) | 1.53 | 1.5 – 1.6 | <.001 |
| Presacral extraperitoneal disease | 3/4 (75%) | 230/346 (67%) | 1.51 | 0.9 – 2.5 | .09 |
| Diffuse small bowel adhesions/thickening | 18/24 (75%) | 215/326 (66%) | 1.55 | 1.5 – 1.6 | <.001 |
| Abdominal ascites (moderate-severe) | 120/154 (78%) | 113/196 (58%) | 2.59 | 2.3 – 3 | <.001 |